Synergo® RITE + MMC

COMBINATION_PRODUCT2 trials

Sponsors

Medical Enterprises Europe B.V., Medical Enterprises Ltd.

Conditions

BCG-Unresponsive Bladder CancerBladder CancerBladder NeoplasmBladder TumorsCancer of BladderCancer of the BladderCarcinoma in Situ of BladderMalignant Tumor of Urinary Bladder

Phase 3

RITE-EUROPE (Radiofrequency-Induced Thermochemotherapy Effect-EUROPE)

WithdrawnNCT02471495

Medical Enterprises Europe B.V.Bladder Cancer

Start: 2016-09-30End: 2020-01-31Updated: 2018-05-07

Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors.

TerminatedNCT03335059

Medical Enterprises Ltd.BCG-Unresponsive Bladder Cancer, Bladder Cancer, Bladder Neoplasm +8

Start: 2019-04-04End: 2020-02-26Updated: 2020-04-15